News

AmerisourceBergen announces new board directors, chairman after stockholders meeting

BY David Salazar
PHILADELPHIA — AmerisourceBergen last week held its annual stockholders meeting, electing 10 new directors to serve one-year terms on the company’s board of directors. Steven Collis, who has served as Amerisource Bergen’s president and CEO since July 2011, was elected chairman of the board, succeeding Richard Gozon. Dr. Jane Henney, chair of the board’s Governance and Nominating Committee, has become the lead independent director. 
 
“On behalf of the entire Board, I want to thank Dick for his many years of exemplary service to AmerisourceBergen,” said Collis. “I am honored to serve as chairman of the board of directors. With the support of the board, we will continue to drive stockholder value through our long-term strategic plans for sustainable growth and the disciplined deployment of capital.”
 
Other new additions to the board are:
  • Douglas R. Conant;
  • D. Mark Durcan;
  • Richard W. Gochnauer;
  • Lon R. Greenberg;
  • Kathleen W. Hyle;
  • Michael J. Long;
  • Henry W. McGee; and
  • Ornella Barra.
All of the members besides Collis and Barra are independent directors, and AmerisourceBergen has detailed biographies for them on its website. 
 
“I extend my sincere gratitude to Dick for the many contributions that he has made to the success of AmerisourceBergen and congratulate him on his retirement,” Henney said. “We will seek to build on the sound practices that were instituted during his tenure, so that AmerisourceBergen continues to be a leader in corporate governance.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Walgreens works with CDC on raising awareness around Zika virus in Puerto Rico

BY Michael Johnsen
DEERFIELD, Ill. – In an effort to curb the spread of Zika virus disease in Puerto Rico, Walgreens is collaborating with the Centers for Disease Control and Prevention and the CDC Foundation to educate the public on preventive steps to avoid Zika, the company announced Monday.
 
In addition, Walgreens is making a $100,000 donation to the CDC Foundation to aid its Zika virus education and prevention efforts.
 
Beginning March 7, all of Walgreens 120 drug stores in Puerto Rico will dedicate space to providing information on CDC-recommended steps to prevent the spread of Zika virus, which is transmitted to people primarily through the bite of an infected mosquito. The CDC, along with other health agencies, is investigating the association between Zika and microcephaly, a birth defect in which the baby’s head is smaller than expected and often has a smaller brain that may not have developed properly.
 
“As a pharmacy that champions everyone’s right to be happy and healthy, we are well positioned to address concerns about how anyone can protect themselves and their families from Zika, while also providing many CDC-recommended prevention products,” stated Richard Ashworth, Walgreens president pharmacy and retail operations. “We’re proud to work closely with the CDC and the CDC Foundation to expand their efforts to prevent the spread of this disease.”
 
The CDC Foundation advances the mission of the CDC through effective philanthropy and public-private partnerships that protect the health, safety and security of America and the world.
 
“We are grateful to Walgreens for its innovative collaboration to help extend CDC’s Zika response,” said Judith Monroe, president and CEO of the CDC Foundation. “These efforts in reaching women with prevention messaging at a critical stage will help in protecting people.”
 
To make Zika virus prevention products easily available and more affordable, Walgreens has lowered the price on CDC-recommended items in its Puerto Rico stores, including insect repellent with DEET, condoms and thermometers to monitor for fever.
 
As growing medical evidence suggests Zika may be sexually transmitted, the CDC recommends women, especially those who are pregnant or may become pregnant, and men who have traveled to or lived in an area with Zika virus, abstain from sex or use condoms during sex.
 
"It is gratifying to see that allies are continuously forming in education and prevention, as in the case of the CDC, the Puerto Rico Department of Health, and Walgreens who are collaborating to provide educational material about and access to Zika prevention products in Walgreens stores throughout Puerto Rico,” said Puerto Rico's Resident Commissioner Pedro Pierluisi.
 
Currently, no vaccine exists to prevent or treat Zika virus. The World Health Organization recently called Zika a public health emergency of international concern and is seeking to develop vaccines, diagnostics and therapeutics to combat the disease. According to the CDC, the most common symptoms of Zika are fever, rash, joint pain or conjunctivitis (red eyes). The illness is usually mild with symptoms lasting for several days to a week after being bitten by a mosquito.
 
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Galderma rolls out next-gen hair regrowth system

BY Gina Acosta

FT. WORTH, Texas — Galderma Laboratories is launching a new product that it says is a game-changer in the hair regrowth category.

Galderma is rolling out qilib Hair Regrowth + Revitalization System and qilib Hair Health Reinforcement Biotin + Multivitamin Supplement. Leveraging the company’s expertise and history in skin health, the qilib portfolio features a dual action system to address hair thinning and hair loss. 

“The qilib Hair Regrowth + Revitalization System is a game changer because it showed clinical results in both men and women in as early as 4 weeks,” says Amy McMichael, M.D., board-certified dermatologist and Professor and Chair of Dermatology at Wake Forest University School of Medicine. “For men and women frustrated with their current hair loss treatments, I encourage them to try qilib and see for themselves what a difference it can make to their hair.”

The qilib system is made of up the Hair Regrowth Treatment, which contains clinically proven, prescription-strength minoxidil specifically formulated for men (5% minoxidil) or women (2% minoxidil), and the Hair Revitalizing Solution formulated with natural botanicals. The Hair Regrowth Treatment works by helping to awaken and restore dormant hair follicles so new hair can grow again, while the qilib Hair Revitalizing Solution nourishes the skin of the scalp with natural botanical ingredients, vitamin C, proteins, lipids and antioxidants. When used as directed, 70% of male and more than 75% of female participants were “satisfied with overall improvement” at 12 weeks of use. Both the Hair Regrowth Treatment and the Hair Revitalizing Solution come in an easy-to-use spray bottle.

“Delivering innovative solutions to improve people’s health and self-confidence is a core value at Galderma,” says Miles Harrison, president and GM of Galderma Laboratories, L.P. “Qilib’s launch embodies our pioneering approach to address skin care issues, including those associated with the hair and scalp, with solutions backed by science. The millions of sufferers of thinning hair and hair loss have had limited options that work, but now, qilib Hair Regrowth + Revitalization System is available to provide fast, visible results in as little as 4 weeks.”

The Qilib Hair Health Reinforcement Biotin + Multivitamin Supplement is made up of 5,000 mcg biotin, a key ingredient to help support healthy hair and scalp, and multiple vitamins, including the daily recommended dose of Vitamins B12, C, D3, E.1 Developed in partnership with, and tested by dermatologists, both qilib Hair Regrowth + Revitalization System and qilib Hair Health Reinforcement Biotin + Multivitamin Supplement are suitable for any hair type.

The qilib Hair Regrowth + Revitalization System  has a suggested retail price of $45.99 for a one month supply and the Qilib Hair Health Reinforcement Biotin + Multivitamin Supplement has a suggested retail price of $9.99 for 30 tablets and $16.99 for 90 tablets and is currently available in CVS, Walgreen’s, Target, Amazon.com, Drugstore.com, and will soon be offered at Walmart. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?